Blood and CSF monitoring of cefepime-induced neurotoxicity: Nine case reports

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1297-1299

  Durand Maugard, Charlotte ^a,b   Lemaire Hurtel, Anne Sophie ^a   Gras Champel, Valérie ^a   Hary, Lionel ^a   Maizel, Julien ^a,b   Prud'homme Bernardy, Aurore ^a   Andréjak, Claire ^a   Andréjak, Michel ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

CSF concentrations; Renal failure; Trough concentrations

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CLONAZEPAM;

ADULT; AGED; BODY FLUID; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONVULSION; DIALYSIS; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; EPILEPTIC STATE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MENTAL DISEASE; NEUROTOXICITY; SOMNOLENCE; TREATMENT DURATION; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD CHEMICAL ANALYSIS; CEPHALOSPORINS; CEREBROSPINAL FLUID; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84859569774     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks012     Document Type: Letter

References (6)

1. Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother 2008; 42: 1843-50.
2. Lemaire-Hurtel AS, Gras-Champel V, Hary L et al. [Recommended dosage adaptation based on renal function is not always sufficient to avoid betalactam antibiotics side effects]. Nephrol Ther 2009; 5: 144-8.
3. Chetaille E, Hary L, de Cagny B et al. [Convulsive crisis associated with an overdose of cefepime]. Therapie 1998; 53: 167-8.
4. Sugimoto M, Uchida I, Mashimo T et al. Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 2003; 45: 304-14.
5. Tam VH, McKinnon PS, Akins RL et al. Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function. Antimicrob Agents Chemother 2003; 47: 1853-61.
6. Lamoth F, Buclin T, Pascual A et al. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother 2010; 54: 4360-7.